VERA: Vera Therapeutics Inc Kompaniya qiymatining sof foydaga nisbati

Vera Corp - VERA emitenti grafik logotipi

Vera Therapeutics, Inc. (VERA) mustahkam ilmiy asosga tayangan holda, buyrak patologiyalarini davolash uchun maqsadli oqsillarni ishlab chiqishga e'tibor qaratadi. Biroq, sog'liqni saqlash gigantlarining bosimi muqobil molekulalarning bozorga tezda olib chiqilishi xavflarini yuzaga keltirmoqda. Joriy tijoratdan oldingi bosqich va ortib borayotgan sinov xarajatlari baholash dinamikasini boshqarmoqda. Kompaniyaning P/E koeffitsiyenti ushbu kurashni aks ettiradi, bunda -4.80 ko'rsatkichi metrikaning holatini ifodalaydi.

Vera Therapeutics (VERA) Narxning foydaga nisbati: 04.07.2022 - 17.11.2026 davri uchun

Vera Corp (VERA) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Vera Therapeutics VERA
Vera Pharma brend mahsuloti

Ushbu ko'rsatkich biznesning bozor qiymatini uning sof foydasi bilan nisbatda aks ettirib, joriy foiz stavkalari prizmasi orqali aktivning premiumini baholash imkonini beradi. Vera Therapeutics, Inc. (VERA) kompaniyasining tarixiy o'rtacha P/E ko'rsatkichini tahlil qilish orqali investor bozor Vera Therapeutics, Inc. (VERA) ning buyrak patologiyalarini davolashdagi maqsadli terapiyasi potensialini qanday baholashini ko'rishi mumkin, bu esa innovatsiya xarajatlari va kapitalning haqiqiy rentabelligi o'rtasidagi muvozanatni belgilaydi.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Dianthus Therapeutics, Inc. - Narx-foyda multiplikatori|P/E multiplikatori PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Kapitalizatsiyaning foydaga nisbati|TRML: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati PGEN|PHAR: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nektar Therapeutics Inc (NKTR)|Narx-foyda koeffitsiyenti UPB|Narx-foyda multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx-foyda koeffitsiyenti IMNM (Immunome Bio)|Biznesning o‘zini qoplash muddati Gossamer Bio, Inc.|P/E multiplikatori KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Kapitalizatsiyaning foydaga nisbati|PVLA - Narxning foydaga nisbati|SVRA - P/E multiplikatori|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|ANAB - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ATXS|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris Therapeutics)|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|CABA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc) - Narxning foydaga nisbati|AVTX (Avalo Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals|Narxning foydaga nisbati Agenus Inc. (AGEN)|Narx-foyda koeffitsiyenti Climb Bio Inc. CLYM|P/E multiplikatori ZURA (Zura Bio Ltd)|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA - P/E multiplikatori|STTK: P/E multiplikatori|Equillium Bio (EQ) - P/E multiplikatori|CNTB (connectbiopharm.com) - P/E multiplikatori|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori adicetbio.com ACET|Celularity - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori